目次

Table of Content

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.8 Market: Cagr Calculation
1.9 List Of Secondary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:

Chapter 2 Executive Summary
2.1 Competition Milieu
2.2 Segment Outlook
2.3 Market Summary, 2020 (USD Million)

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Parent Market Lineage
3.3 Ancillary Market Lineage
3.4 Market Dynamics
3.4.1 Market Drivers Analysis
3.4.1.1 Growing Pipeline Of Cell And Gene Therapy
3.4.1.2 Supportive Regulatory Bodies
3.4.1.3 Increase In Investment By Government And Private Players
3.4.2 Market Restraint Analysis
3.4.2.1 Technological Challenges Associated With Manufacturing
3.4.2.2 High Cost Of Manufacturing
3.4.3 Market Opportunity Analysis
3.4.3.1 Rising Pressure On Drug Developers/Manufacturers To Meet The Growing Market Demand
3.4.3.2 Expansion In Potential Markets Such As Asia Pacific And Latin America
3.4.4 Market Challenge Analysis
3.4.4.1 Lack Of Manufacturing Capacity
3.5 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
3.6 Porter’s Five Forces Analysis
3.7 Major Deals And Strategic Alliances Analysis
3.7.1 Mergers And Acquisitions
3.7.2 Technological Collaborations
3.7.3 Licensing And Partnerships
3.8 Covid-19 Impact Analysis
3.8.1 Challenge Analysis
3.8.2 Opportunity Analysis
3.8.3 Key Developments And Activities

Chapter 4 Competitive Analysis
4.1 Recent Developments And Impact Analysis By Key Market Participants
4.2 Company Mapping, By Location, Purpose, Scale Of Operation, Source Of Cell, Regulatory Compliant
4.3 List Of Potential End Users
4.4 List Of Emerging Players
4.5 Market Differentiators
4.6 Competitive Dashboard Analysis
4.7 Regional Network Map

Chapter 5 Therapy Type Business Analysis
5.1 Cell And Gene Therapy Manufacturing Market: Therapy Type Movement Analysis
5.2 Cell Therapy Manufacturing
5.2.1 Cell Therapy Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)
5.2.2 Stem Cell Therapy
5.2.2.1 Cell Therapy Manufacturing Market Estimates And Forecast For Stem Cell Therapy, 2017 - 2028 (USD Million)
5.2.3 Non-Stem Cell Therapy
5.2.3.1 Cell Therapy Manufacturing Market Estimates And Forecast For Non-Stem Cell Therapy, 2017 - 2028 (USD Million)
5.3 Gene Therapy Manufacturing
5.3.1 Gene Therapy Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 6 Scale Business Analysis
6.1 Cell And Gene Therapy Manufacturing Market: Scale Movement Analysis
6.2 Pre-Commercial/R&D Scale Manufacturing
6.2.1 Cell And Gene Therapy Manufacturing market Estimates And Forecast For Pre-Commercial/R&D Scale Manufacturing, 2017 - 2028 (USD Million)
6.3 Commercial Scale Manufacturing
6.3.1 Cell And Gene Therapy Manufacturing market Estimates And Forecast For Commercial Scale Manufacturing, 2017 - 2028 (USD Million)

Chapter 7 Mode Business Analysis
7.1 Cell And Gene Therapy Manufacturing Market: Mode Movement Analysis
7.2 Contract Manufacturing
7.2.1 Cell And Gene Therapy Manufacturing market For Contract Manufacturing, 2017 - 2028 (USD Million)
7.3 In-House Manufacturing
7.3.1 Cell And Gene Therapy Manufacturing market For In-House Manufacturing, 2017 - 2028 (USD Million)

Chapter 8 Workflow Business Analysis
8.1 Cell And Gene Therapy Manufacturing Market: Workflow Movement Analysis
8.2 Cell Processing
8.2.1 Cell And Gene Therapy Manufacturing Market For Cell Processing, 2017 - 2028 (USD Million)
8.3 Cell Banking
8.3.1 Cell And Gene Therapy Manufacturing Market For Cell Banking, 2017 - 2028 (USD Million)
8.4 Process Development
8.4.1 Cell And Gene Therapy Manufacturing Market For Process Development, 2017 - 2028 (USD Million)
8.5 Fill And Finish Operations
8.5.1 Cell And Gene Therapy Manufacturing Market For Fill And Finish Operations, 2017 - 2028 (USD Million)
8.6 Analytical And Quality Testing
8.6.1 Cell And Gene Therapy Manufacturing Market For Analytical And Quality Testing, 2017 - 2028 (USD Million)
8.7 Raw Material Testing
8.7.1 Cell And Gene Therapy Manufacturing Market For Raw Material Testing, 2017 - 2028 (USD Million)
8.8 Vector Production
8.8.1 Cell And Gene Therapy Manufacturing Market For Vector Production, 2017 - 2028 (USD Million)
8.9 Others
8.9.1 Cell And Gene Therapy Manufacturing Market For Other Workflows, 2017 - 2028 (USD Million)

Chapter 9 Regional Business Analysis
9.1 Cell And Gene Therapy Manufacturing Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Cell And Gene Therapy Manufacturing Market Estimates And Forecast,2017 - 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.2.2.2 U.S. Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.2.2.3 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.2.2.4 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.2.2.5 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.2.3.2 Canada Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.2.3.3 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.2.3.4 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.2.3.5 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3 Europe
9.3.1 Europe Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
9.3.2 Germany
9.3.2.1 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.3.2.2 Germany Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.3.2.3 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.3.2.4 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.3.2.5 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.3.3.2 U.K. Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.3.3.3 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.3.3.4 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.3.3.5 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.4 France
9.3.4.1 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.3.4.2 France Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.3.4.3 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.3.4.4 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.3.4.5 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.5 Italy
9.3.5.1 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.3.5.2 Italy Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.3.5.3 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.3.5.4 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.3.5.5 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.3.6.2 Spain Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.3.6.3 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.3.6.4 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.3.6.5 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.4.2.2 Japan Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.4.2.3 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.4.2.4 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.4.2.5 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.3 China
9.4.3.1 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.4.3.2 China Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.4.3.3 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.4.3.4 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.4.3.5 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.4 India
9.4.4.1 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.4.4.2 India Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.4.4.3 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.4.4.4 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.4.4.5 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.5 South Korea
9.4.5.1 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.4.5.2 South Korea Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.4.5.3 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.4.5.4 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.4.5.5 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.5.2.2 Brazil Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.5.2.3 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.5.2.4 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.5.2.5 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.5.3.2 Mexico Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.5.3.3 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.5.3.4 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.5.3.5 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.6 Middle East & Africa
9.6.1 Middle East & Africa Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.6.2.2 South Africa Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.6.2.3 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.6.2.4 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.6.2.5 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
9.6.3.2 Saudi Arabia Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
9.6.3.3 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
9.6.3.4 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
9.6.3.5 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)

Chapter 10 Company Profiles
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 Thermofisher Scientific
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 strategic Initiatives
10.3.2 MERCK KGAA.
10.3.2.1 Company Overview
10.3.2.2 Milliporesigma
10.3.2.3 Financial Performance
10.3.2.4 Product Benchmarking
10.3.2.5 Strategic Initiatives
10.3.3 LONZA
10.3.3.1 Company Overview
10.3.3.2 Financial Performace
10.3.3.3 Product Benchmarking
10.3.3.4 Strategic Initiatives
10.3.4 CATALENT INC.
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Stretegic Initiatives
10.3.5 TAKARA BIO INC.
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 F.HOFFMANN-LA ROCHE LTD
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 WUXI ADVANCED THERAPIES
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 SAMSUNG BIOLOGICS
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
10.3.9.1 Company Overview
10.3.9.2 Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.4 Strategic Initiatives
10.3.10 NOVARTIS AG
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Strategic Initiatives
10.3.11 HITACHI CHEMICAL CO LTD.
10.3.11.1 Company Overview
10.3.11.2 Apceth Biopharma
10.3.11.3 Financial Performance
10.3.11.4 Product Benchmarking
10.3.11.5 Strategic Initiatives
10.3.12 CELLULAR THERAPEUTICS.
10.3.12.1 Company Overview
10.3.12.2 Financial Performance
10.3.12.3 Product Benchmarking
10.3.13 MILTENYI BIOTECH.
10.3.13.1 Company Overview
10.3.13.2 Financial Performance
10.3.13.3 Product Benchmarking
10.3.13. 4strategic Initiatives
10.3.14 BLUEBIRD BIO INC.
10.3.14.1 Company Overview
10.3.14.2 Financial Performance
10.3.14.3 Product Benchmarking
10.3.14.4 Strategic Initiatives